Spatial Genomics
PrivateLast Round
Series A
Feb 23, 2022
Total Funding Raised
$56.92M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Spatial Genomics is a biotechnology company that develops a spatial single-cell multiomics analysis platform based on seqFISH technology to map gene expression and cellular interactions within tissue microenvironments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery, Data Visualization
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spatial Genomics Comparables
Compare Spatial Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resolve Biosciences | 86% | |
| Stellaromics | 84% | |
| Vizgen | 82% |
Spatial Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 23, 2022 | ||||
| Grant | Oct 28, 2020 | ||||
| Grant | Jun 21, 2019 | ||||
| Grant | Jul 1, 2018 |
Spatial Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| National Cancer Institute | Grant |
| National Institute on Aging | Grant |
| Chan Zuckerberg Initiative | Grant |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 79% MoM, reaching 3K.
- Jun 24, 2026
Monthly visitors increased 64% MoM.
Recent news
Latest coverage and updates
- files_suit_againstAug 7, 2026
Spatial Genomics, Inc. files suit against 10x Genomics, Inc..
Spatial Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Spatial Genomics's valuation, stock price, and market status.
Is Spatial Genomics a public or private company?
Spatial Genomics is a private company.
What is the current stock price of Spatial Genomics?
Spatial Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Spatial Genomics worth (valuation)?
Valuation information for Spatial Genomics is not publicly available.
Can I buy Spatial Genomics stock?
Spatial Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Spatial Genomics's last funding round?
Spatial Genomics's most recent funding round was Series A on February 23, 2022.
Who are the main investors in Spatial Genomics?
Key investors in Spatial Genomics include National Institute of Mental Health, National Cancer Institute, National Institute on Aging, Chan Zuckerberg Initiative, National Institute of General Medical Sciences.
Will Spatial Genomics IPO soon?
No public IPO plans have been announced for Spatial Genomics.
How can I track Spatial Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spatial Genomics's secondary market activity and sign up for updates.